Resverlogix Corp. (TSE:RVX – Get Free Report)’s share price crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$0.10 and traded as low as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 47,615 shares traded.
Resverlogix Trading Down 9.5%
The stock has a market cap of C$30.11 million, a price-to-earnings ratio of -4.75 and a beta of 0.41. The business’s 50 day moving average is C$0.10 and its 200 day moving average is C$0.10. The company has a debt-to-equity ratio of -83.11, a current ratio of 0.03 and a quick ratio of 0.04.
Resverlogix (TSE:RVX – Get Free Report) last posted its quarterly earnings results on Friday, May 15th. The biotechnology company reported C$0.01 earnings per share for the quarter. As a group, equities analysts expect that Resverlogix Corp. will post -0.22 earnings per share for the current fiscal year.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Read More
- Five stocks we like better than Resverlogix
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
